Stock Track | REMEGEN Plummets 6.51% Intraday on Sharp Q1 Profit Decline and Biotech Sector Weakness

Stock Track05-04

REMEGEN's stock plummeted 6.51% during intraday trading on Monday, reflecting significant selling pressure.

The sharp decline follows the company's recently disclosed first-quarter results, which showed a steep sequential drop in net profit. Despite year-over-year revenue growth, net profit attributable to shareholders fell approximately 73% quarter-over-quarter. This sharp earnings contraction, coupled with a prior period of stock price gains, has triggered profit-taking activity. Additionally, sustained net selling by southbound capital over recent weeks has contributed to capital outflow pressures.

The broader biotechnology sector also exhibited weakness during the session, with several major peers trading lower, which further weighed on investor sentiment towards REMEGEN.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1120099224?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-05-04 09:49","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1120099224","market":"sg","top_or_hot":-1,"title":"Stock Track | REMEGEN Plummets 6.51% Intraday on Sharp Q1 Profit Decline and Biotech Sector Weakness","media":"Stock Track","content":"<p>REMEGEN's stock plummeted 6.51% during intraday trading on Monday, reflecting significant selling pressure.</p><p>The sharp decline follows the company's recently disclosed first-quarter results, which showed a steep sequential drop in net profit. Despite year-over-year revenue growth, net profit attributable to shareholders fell approximately 73% quarter-over-quarter. This sharp earnings contraction, coupled with a prior period of stock price gains, has triggered profit-taking activity. Additionally, sustained net selling by southbound capital over recent weeks has contributed to capital outflow pressures.</p><p>The broader biotechnology sector also exhibited weakness during the session, with several major peers trading lower, which further weighed on investor sentiment towards REMEGEN.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | REMEGEN Plummets 6.51% Intraday on Sharp Q1 Profit Decline and Biotech Sector Weakness</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | REMEGEN Plummets 6.51% Intraday on Sharp Q1 Profit Decline and Biotech Sector Weakness\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2026-05-04 09:49</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>REMEGEN's stock plummeted 6.51% during intraday trading on Monday, reflecting significant selling pressure.</p><p>The sharp decline follows the company's recently disclosed first-quarter results, which showed a steep sequential drop in net profit. Despite year-over-year revenue growth, net profit attributable to shareholders fell approximately 73% quarter-over-quarter. This sharp earnings contraction, coupled with a prior period of stock price gains, has triggered profit-taking activity. Additionally, sustained net selling by southbound capital over recent weeks has contributed to capital outflow pressures.</p><p>The broader biotechnology sector also exhibited weakness during the session, with several major peers trading lower, which further weighed on investor sentiment towards REMEGEN.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"09995","symbol_name":"荣昌生物","start_time":0,"source_url":"","article_id":"1120099224","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1120099224","pubTimestamp":1777859379,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"REMEGEN's stock plummeted 6.51% during intraday trading on Monday, reflecting significant selling pressure.The sharp decline follows the company's recently disclosed first-quarter results, which...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"09995":"荣昌生物"},"translate_title":"个股赛道|REMEGEN盘中暴跌6.51%受Q1盈利大幅下滑及生物科技板块疲软影响","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"09995":1},"content_text":"REMEGEN's stock plummeted 6.51% during intraday trading on Monday, reflecting significant selling pressure.The sharp decline follows the company's recently disclosed first-quarter results, which showed a steep sequential drop in net profit. Despite year-over-year revenue growth, net profit attributable to shareholders fell approximately 73% quarter-over-quarter. This sharp earnings contraction, coupled with a prior period of stock price gains, has triggered profit-taking activity. Additionally, sustained net selling by southbound capital over recent weeks has contributed to capital outflow pressures.The broader biotechnology sector also exhibited weakness during the session, with several major peers trading lower, which further weighed on investor sentiment towards REMEGEN.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-2","news_tag":"movement","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.42.2","shortVersion":"4.42.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1120099224","isCrawlerRequest":true}